Drug Shortage Report for HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ

Last updated on 2025-12-05 History
Report ID 269849
Drug Identification Number 02209721
Brand name HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ
Common or Proper name Heparin Sodium in Dextrose
Company Name B. BRAUN MEDICAL INC
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM DEXTROSE
Strength(s) 10000UNIT 5G
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250mL
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2025-10-24
Actual start date
Estimated end date 2025-11-30
Actual end date 2025-12-04
Shortage status Resolved
Updated date 2025-12-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 824 TWELFTH AVENUE
BETHLEHEM, PENNSYLVANIA
UNITED STATES 18018
Company contact information Cindy Katsempris; cindy.katsempris@bbraunusa.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2025-12-05 English Compare
v6 2025-12-04 French Compare
v5 2025-12-04 English Compare
v4 2025-12-04 English Compare
v3 2025-10-25 English Compare
v2 2025-10-17 French Compare
v1 2025-10-17 English Compare

Showing 1 to 7 of 7